155 related articles for article (PubMed ID: 26186447)
21. ICP0 is not required for efficient stress-induced reactivation of herpes simplex virus type 1 from cultured quiescently infected neuronal cells.
Miller CS; Danaher RJ; Jacob RJ
J Virol; 2006 Apr; 80(7):3360-8. PubMed ID: 16537603
[TBL] [Abstract][Full Text] [Related]
22. Herpes simplex virus 1 ICP27 is required for transcription of two viral late (gamma 2) genes in infected cells.
Jean S; LeVan KM; Song B; Levine M; Knipe DM
Virology; 2001 May; 283(2):273-84. PubMed ID: 11336552
[TBL] [Abstract][Full Text] [Related]
23. ICP0 gene expression is a herpes simplex virus type 1 apoptotic trigger.
Sanfilippo CM; Blaho JA
J Virol; 2006 Jul; 80(14):6810-21. PubMed ID: 16809287
[TBL] [Abstract][Full Text] [Related]
24. Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins.
Kouvatsis V; Argnani R; Tsitoura E; Arsenakis M; Georgopoulou U; Mavromara P; Manservigi R
Virus Res; 2007 Jan; 123(1):40-9. PubMed ID: 16989918
[TBL] [Abstract][Full Text] [Related]
25. Herpes simplex virus type 1 ICP0 protein mediates activation of adeno-associated virus type 2 rep gene expression from a latent integrated form.
Geoffroy MC; Epstein AL; Toublanc E; Moullier P; Salvetti A
J Virol; 2004 Oct; 78(20):10977-86. PubMed ID: 15452218
[TBL] [Abstract][Full Text] [Related]
26. Characterization of antiproliferative and cytotoxic properties of the HSV-1 immediate-early ICPo protein.
Cuchet D; Ferrera R; Lomonte P; Epstein AL
J Gene Med; 2005 Sep; 7(9):1187-99. PubMed ID: 15852412
[TBL] [Abstract][Full Text] [Related]
27. ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency.
Halford WP; Schaffer PA
J Virol; 2001 Apr; 75(7):3240-9. PubMed ID: 11238850
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0.
Brehm M; Samaniego LA; Bonneau RH; DeLuca NA; Tevethia SS
Virology; 1999 Apr; 256(2):258-69. PubMed ID: 10191191
[TBL] [Abstract][Full Text] [Related]
29. Deletion of a Predicted β-Sheet Domain within the Amino Terminus of Herpes Simplex Virus Glycoprotein K Conserved among Alphaherpesviruses Prevents Virus Entry into Neuronal Axons.
Jambunathan N; Charles AS; Subramanian R; Saied AA; Naderi M; Rider P; Brylinski M; Chouljenko VN; Kousoulas KG
J Virol; 2015 Dec; 90(5):2230-9. PubMed ID: 26656706
[TBL] [Abstract][Full Text] [Related]
30. The role of protein kinase activity expressed by the UL13 gene of herpes simplex virus 1: the activity is not essential for optimal expression of UL41 and ICP0.
Tanaka M; Nishiyama Y; Sata T; Kawaguchi Y
Virology; 2005 Oct; 341(2):301-12. PubMed ID: 16095647
[TBL] [Abstract][Full Text] [Related]
31. A block in glycoprotein processing correlates with small plaque morphology and virion targetting to cell-cell junctions for an oral and an anal strain of herpes simplex virus type-1.
Dick JW; Rosenthal KS
Arch Virol; 1995; 140(12):2163-81. PubMed ID: 8572939
[TBL] [Abstract][Full Text] [Related]
32. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
Friedman HM; Wang L; Fishman NO; Lambris JD; Eisenberg RJ; Cohen GH; Lubinski J
J Virol; 1996 Jul; 70(7):4253-60. PubMed ID: 8676446
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of HSV-1 cell-free virion release by the envelope protein gC.
Frost TC; Salnikov M; Rice SA
Virology; 2024 Aug; 596():110120. PubMed ID: 38805801
[TBL] [Abstract][Full Text] [Related]
34. Herpes simplex virus type 2 glycoprotein G-negative clinical isolates are generated by single frameshift mutations.
Liljeqvist JA; Svennerholm B; Bergström T
J Virol; 1999 Dec; 73(12):9796-802. PubMed ID: 10559290
[TBL] [Abstract][Full Text] [Related]
35. Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells.
Laquerre S; Anderson DB; Stolz DB; Glorioso JC
J Virol; 1998 Dec; 72(12):9683-97. PubMed ID: 9811702
[TBL] [Abstract][Full Text] [Related]
36. Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1.
Trybala E; Roth A; Johansson M; Liljeqvist JA; Rekabdar E; Larm O; Bergström T
Virology; 2002 Oct; 302(2):413-9. PubMed ID: 12441085
[TBL] [Abstract][Full Text] [Related]
37. Cloning and expression of the complement receptor glycoprotein C from Herpesvirus simiae (herpes B virus): protection from complement-mediated cell lysis.
Huemer HP; Wechselberger C; Bennett AM; Falke D; Harrington L
J Gen Virol; 2003 May; 84(Pt 5):1091-1100. PubMed ID: 12692273
[TBL] [Abstract][Full Text] [Related]
38. Resistance of herpes simplex virus type 2 to neomycin maps to the N-terminal portion of glycoprotein C.
Oyan AM; Dolter KE; Langeland N; Goins WF; Glorioso JC; Haarr L; Crumpacker CS
J Virol; 1993 May; 67(5):2434-41. PubMed ID: 8386261
[TBL] [Abstract][Full Text] [Related]
39. Subcellular localization of herpes simplex virus type 1 UL51 protein and role of palmitoylation in Golgi apparatus targeting.
Nozawa N; Daikoku T; Koshizuka T; Yamauchi Y; Yoshikawa T; Nishiyama Y
J Virol; 2003 Mar; 77(5):3204-16. PubMed ID: 12584344
[TBL] [Abstract][Full Text] [Related]
40. The syn3 strain HSZP of herpes simplex virus type 1 (HSV-1) is not pathogenic for mice and shows limited neural spread.
Rajcáni J; Vojvodová A; Matis J; Kúdelová M; Dragúnová J; Krivjanská M; Zelník V
Virus Res; 1996 Jul; 43(1):33-44. PubMed ID: 8822632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
